Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Squadron Capital Management LLC | 4.13M | $20.0M | 5.76% | +95.0K | 2026-06-30 |
| 5AM Venture Management, LLC | 3.95M | $19.0M | 5.51% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.75M | $18.0M | 5.24% | +2.48M | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 3.02M | $14.0M | 4.22% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.84M | $13.0M | 3.96% | +525.0K | 2026-06-30 |
| CITADEL ADVISORS LLC | 2.34M | $11.0M | 3.26% | +581.5K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.61M | $7.0M | 2.25% | -329.1K | 2026-06-30 |
| Opaleye Management Inc. | 1.41M | $6.0M | 1.97% | -- | 2026-06-30 |
| ORBIMED ADVISORS LLC | 1.39M | $6.0M | 1.94% | -- | 2026-06-30 |
| Decheng Capital LLC | 1.32M | $6.0M | 1.85% | -- | 2026-06-30 |
